John R. Traynor

Eleven Therapeutics Corp

NIH Rank #3137
  • Early Career
  • Mentor
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#3,137
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.7M across 3 grants · National rank #3137.

Top grants by award amount

John R. Traynor's NIH grant portfolio, ranked by award amount.

  • 2R42DA056254-02R42
    Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorder
    $1.6M
    award amount
  • 5R37DA039997-10R37
    Allosteric Modulation of the Mu-Opioid Receptor
    $648K
    award amount
  • 1T32DA060142-01T32
    Postdoctoral Training in the Biology of Drug Abuse
    $505.6K
    award amount

Affiliations

Institutions that have administered grants for John R. Traynor.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Eleven Therapeutics Corp
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3137
  6. 2024
    Entered Top 25% Nationally
    Ranked #3137
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions